Total Payments
$28,006
2024 Payments
$25,352
Companies
31
Transactions
188
Medicare Patients
2,265
Medicare Billing
$234,479
Payment Breakdown by Category
Other$22,750 (81.2%)
Food & Beverage$4,487 (16.0%)
Travel$747.65 (2.7%)
Education$21.56 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,750 | 8 | 81.2% |
| Food and Beverage | $4,487 | 177 | 16.0% |
| Travel and Lodging | $747.65 | 2 | 2.7% |
| Education | $21.56 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $17,394 | 94 | $0 (2024) |
| PFIZER INC. | $8,894 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $204.16 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $149.57 | 3 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $125.07 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $123.95 | 8 | $0 (2024) |
| Medical Device Business Services, Inc. | $116.50 | 1 | $0 (2019) |
| Allergan Inc. | $106.92 | 6 | $0 (2018) |
| Covidien LP | $87.56 | 5 | $0 (2019) |
| Phathom Pharmaceuticals, Inc. | $87.48 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,352 | 75 | ABBVIE INC. ($16,288) |
| 2023 | $1,069 | 34 | AbbVie Inc. ($643.97) |
| 2022 | $223.55 | 8 | E.R. Squibb & Sons, L.L.C. ($125.07) |
| 2021 | $90.18 | 5 | AbbVie Inc. ($56.50) |
| 2019 | $131.41 | 2 | Medical Device Business Services, Inc. ($116.50) |
| 2018 | $149.07 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($52.57) |
| 2017 | $991.05 | 54 | AbbVie, Inc. ($332.09) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | VELSIPITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,250.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $116.57 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $36.69 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 443 | 553 | $208,402 | $45,071 |
| 2022 | 13 | 520 | 609 | $346,116 | $53,395 |
| 2021 | 13 | 540 | 607 | $392,471 | $55,181 |
| 2020 | 13 | 762 | 926 | $538,788 | $80,833 |
Total Patients
2,265
Total Services
2,695
Medicare Billing
$234,479
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 139 | $33,360 | $8,796 | 26.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 39 | 39 | $29,915 | $7,702 | 25.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 62 | 62 | $37,606 | $5,379 | 14.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 69 | 69 | $28,752 | $5,357 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 59 | $22,458 | $4,686 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 77 | $20,727 | $4,295 | 20.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 52 | 53 | $13,515 | $3,483 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $9,757 | $2,187 | 22.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 14 | $7,560 | $1,919 | 25.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,752 | $1,266 | 26.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 41 | 41 | $43,943 | $8,042 | 18.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $70,023 | $7,347 | 10.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 132 | $28,380 | $7,224 | 25.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 101 | 101 | $91,563 | $6,872 | 7.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 79 | $21,429 | $4,676 | 21.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 26 | 26 | $24,071 | $4,655 | 19.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 37 | 37 | $11,359 | $3,022 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 34 | $13,056 | $2,945 | 22.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $9,430 | $2,399 | 25.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 14 | 14 | $10,700 | $2,262 | 21.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $11,792 | $1,743 | 14.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $7,820 | $1,642 | 21.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $2,550 | $565.46 | 22.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 97 | 99 | $40,689 | $10,321 | 25.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 70 | 70 | $94,150 | $9,099 | 9.7% |
About Dr. Ilan Aharoni, M.D
Dr. Ilan Aharoni, M.D is a Gastroenterology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851423701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilan Aharoni, M.D has received a total of $28,006 in payments from pharmaceutical and medical device companies, with $25,352 received in 2024. These payments were reported across 188 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,750).
As a Medicare-enrolled provider, Aharoni has provided services to 2,265 Medicare beneficiaries, totaling 2,695 services with total Medicare billing of $234,479. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Orlando, FL
- Active Since 03/09/2007
- Last Updated 07/02/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1851423701
Products in Payments
- SKYRIZI (Biological) $13,673
- VELSIPITY (Drug) $8,710
- RINVOQ (Biological) $3,038
- Humira (Biological) $221.52
- ENTYVIO (Biological) $204.16
- XELJANZ (Drug) $183.95
- LINX Reflux Management System (Device) $132.40
- ZEPOSIA (Drug) $125.07
- ZINPLAVA (Biological) $117.21
- VIBERZI (Drug) $115.71
- HUMIRA (Biological) $95.89
- LINZESS (Drug) $93.29
- VOQUEZNA (Drug) $87.48
- Creon (Drug) $80.79
- PillCam (Device) $72.65
- XIFAXAN (Drug) $66.23
- RELISTOR (Drug) $61.81
- Mavyret (Drug) $54.68
- TREMFYA (Drug) $52.63
- Cimzia (Drug) $46.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Orlando
Dr. Samuel Giday, M.d, M.D
Gastroenterology — Payments: $2.6M
Gastroenterology $2.6M
Jennifer Seminerio-Diehl, Md, MD
Gastroenterology — Payments: $814,283
Gastroenterology $814,283
Dr. Robert Hawes, Md, MD
Gastroenterology — Payments: $593,475
Gastroenterology $593,475
Muhammad Hasan, Md, MD
Gastroenterology — Payments: $261,176
Gastroenterology $261,176
Dr. Kenneth Feuer, Md, MD
Gastroenterology — Payments: $142,471
Gastroenterology $142,471
Dr. Natalie Cosgrove, Md, MD
Gastroenterology — Payments: $132,710
Gastroenterology $132,710